Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3321-x
Published Online: 2017-04-28
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nishijima-Futami, Yu
Minami, Seigo
Futami, Shinji
Koba, Taro
Higashiguchi, Masayoshi
Tamiya, Motohiro
Suzuki, Hidekazu
Hirashima, Tomonori
Komuta, Kiyoshi
Kijima, Takashi
License valid from 2017-04-28